Sinus Dilation Devices Market to Witness Comprehensive Growth by 2026

Sinuses are the hollow sacks in the head which are responsible for secretion of mucus and provide resonance to the voice. The mucus secreted by the sinuses prevents the nasal cavity from drying and works by trapping the foreign particles that enter the nasal passage and reaching to lungs. The sinuses have an opening that allows the mucus to drain from and flow into nasal passage, however in some cases the sinus opening gets blocked, and the mucus remains logged into the sinus causing headache, congestion, and inflammation of the sinus, it also increases the risk of causing an infection, this condition is termed as sinusitis.

Request for TOC @
https://www.futuremarketinsights.com/toc/rep-gb-1802

Depending on the duration of the symptoms, sinusitis is classified into three types, acute, sub - acute and chronic. The treatment of sinusitis depends on the longevity of the infection. To relieve the patient from the symptoms, treatment options like drugs, surgery, and physical therapy are available. In the chronic case where the sinuses remain blocked for a longer time, the doctors opt for surgery. The rhinoplasty surgery is a procedure in which surgeons dilate the sinuses to relieve the mucus and decrease pressure in the sinuses.

The growing incidence of sinusitis is expected to boost demand for sinus dilation devices worldwide. According to the Center of Disease Control and Prevention (CDC), in the U.S. nearly 12% of the population in the age group of 18 years and above suffer from sinusitis. The increasing rate of chronic sinusitis is expected to provide high growth opportunities for the sinus dilation devices manufacturers.

Moreover, the development of new devices and technologies like balloon sinus dilation systems more physicians are expected to opt for these devices for treating sinusitis, as these devices are more effective and less invasive the risk to patients is minimal, which in turn is expected to create high demand from the patients as well as physicians. Several companies like Medtronic and Acclarent, Inc. are focused on the development of new products for sinus dilation which in turn is expected to increase adoption of new technology-based products owing to increasing availability of these products in the market. However, prescription drugs like antibiotics and decongestants, being the primary treatment method for treatment of sinusitis the adoption of devices for sinus dilation is comparatively low, which in turn is expected to reduce revenue growth of the sinus dilation devices market.

Globally the sinus dilation devices market is expected to witness robust growth over the forecast period owing to new product development, products which are less invasive and easy to use in physician office settings are expected to gain traction over the forecast period. Moreover increasing distribution network of manufacturers and growing awareness among the physicians is expected to create high growth opportunities for the stakeholders of sinus dilation devices market.

Request to view Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1802

Some key players in the sinus dilation devices market include Acclarent, Inc., Medtronic, Entellus Medical, Inc., SinuSys Corporation., Smith & Nephew plc. Aetna, Inc., KARL STORZ GmbH & Co. KG, Olympus Corporation and others

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.